Diseases, Conditions, Syndromes

Skin diseases are more common than we think

Skin diseases are ranked as the fourth most common cause of human illness, but many affected people do not consult a physician. A new Journal of the European Academy of Dermatology and Venereology study estimates the prevalence ...

Diseases, Conditions, Syndromes

Poor persistence/Adherence with long-term topical AK treatment

(HealthDay)—A considerable proportion of patients with actinic keratosis (AK) receiving long-term topical treatment have poor persistence or adherence, according to a study published online April 18 in the British Journal ...

Diseases, Conditions, Syndromes

How plague pathogens trick the immune system

Yersinia have spread fear and terror, especially in the past, but today the plague pathogens have still not been completely eradicated. The bacteria inject various enzymes, including the enzyme YopO, into the macrophages ...

Oncology & Cancer

Added benefit of ingenol mebutate is not proven

The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act ...

Oncology & Cancer

Tirbanibulin superior to placebo for actinic keratosis

(HealthDay)—Tirbanibulin is superior to vehicle at two months for the treatment of actinic keratosis, but almost half of patients who had a complete response experienced recurrence of lesions at one year, according to a ...

page 7 from 8